Apply for JIO IPO - India’s Mega IPO Is Here!

Apply for JIO IPO -

Angel One - Share Market Trading and Stock Broking
Skip to main content

Live IRulya Therapeutics Inc. Common Stock Share Price Chart

O H L

IRulya Therapeutics Inc. Common Stock Performance Overview

Days Range
▼
$31.73Low
$33.00High

Markets Today

Previous Close$32.03
Open$31.73
Volume34,184
Day's Range$31.73 - $33.00
52W RangeNA
Market Cap$33.80 M

Historical Performance

1M ReturnsNA
3M ReturnsNA
6M ReturnsNA
1Y ReturnsNA
5Y ReturnsNA
10Y ReturnsNA

IRulya Therapeutics Inc. Common Stock Fundamentals

Market Cap$33.80 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A
Market Cap$33.80 M
Dividend yieldN/A
PE RatioN/A
PEG RatioN/A
RevenueN/A
ROE TTMN/A
EPS TTMN/A
Quarterly Earnings Growth YOYN/A
PB RatioN/A
EBITDAN/A
Profit MarginN/A

IRulya Therapeutics Inc. Common Stock Return Calculator

The IRulya Therapeutics Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
Invest in USA Stock Today

About IRulya Therapeutics Inc. Common Stock

IRulya Therapeutics Inc is committed to transforming the lives of patients with serious, underserved diseases by developing disease-modifying therapies. The company is currently developing LAM-001 for the treatment of pulmonary hypertension associated with interstitial lung disease (PH-ILD), bronchiolitis obliterans syndrome post-lung transplant (BOS), and sarcoidosis-associated pulmonary hypertension (SAPH). A Phase 2a study in PH patients has been completed; a Phase 2 clinical study in BOS patients is ongoing; a Phase 2b clinical study in PH-ILD is ongoing; and a Phase 2 clinical study in SAPH is ongoing.

FAQs

IRulya Therapeutics Inc. Common Stock (IRLA) share price as of October 19, 2026 is $28.00. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the IRulya Therapeutics Inc. Common Stock (IRLA) Share by opening an international trading account with Angel One.
Purchasing IRulya Therapeutics Inc. Common Stock (IRLA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying IRulya Therapeutics Inc. Common Stock (IRLA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of IRulya Therapeutics Inc. Common Stock (IRLA) or any other US company shares in Angel One for any dollar amount.
The market capitalization of IRulya Therapeutics Inc. Common Stock on October 19, 2026, is $33.80 M.
IRulya Therapeutics Inc. Common Stock operates in the null sector, specifically in the null industry.
In order to invest in IRulya Therapeutics Inc. Common Stock (IRLA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL